Which ILAR categories of juvenile idiopathic arthritis (JIA) fall into the ACR treatment group with active sacroiliac arthritis?

Updated: Jul 25, 2019
  • Author: David D Sherry, MD; Chief Editor: Lawrence K Jung, MD  more...
  • Print

This group includes all patients with clinical and imaging evidence of active sacroiliac arthritis. It may include patients from any of the ILAR JIA categories. [2]

Use of a TNF-α inhibitor is recommended more readily for patients in this group. A TNF-α inhibitor may be started after failure of an adequate trial of NSAIDs or after 3-6 months (depending on disease characteristics and severity) of methotrexate or sulfasalazine proves inadequate.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!